Trials / Completed
CompletedNCT00227227
Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
Observational Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 750 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the incidence of adverse events for patients with AS treated with Enbrel in usual care settings.
Conditions
Timeline
- Start date
- 2004-05-01
- Completion
- 2007-06-01
- First posted
- 2005-09-27
- Last updated
- 2007-12-10
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00227227. Inclusion in this directory is not an endorsement.